Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment

L Paulis, S Liskova, M Pinterova, Z Dobesova, J Kunes, J Zicha

. 2007 ; 191 (4) : 255-266.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc10026684
E-zdroje

NLK Medline Complete (EBSCOhost) od 2006-01-01 do Před 1 rokem
Wiley Online Library (archiv) od 1889-01-01 do 2012-12-31

AIM: The relationship between increased sympathetic tone and enhanced activity of L-type voltage-dependent Ca2+ channels (L-VDCC) in spontaneously hypertensive rats (SHR) was studied using in vivo and in vitro approaches. METHODS: The effects of acute L-VDCC blockade on sympathetic vasoconstriction or blood pressure (BP) and the contribution of calcium influx to norepinephrine (NE)-induced arterial contraction were investigated in 10-week-old SHR and in age-matched SHR made normotensive by chronic captopril treatment from weaning. RESULTS: Blood pressure fall occurring after acute ganglionic or L-VDCC blockade was enhanced in SHR. Ganglionic blockade eliminated strain differences in BP response to acute L-VDCC blockade and vice versa, suggesting that enhanced contribution of L-VDCC is responsible for augmented sympathetic vasoconstriction in SHR. Both phasic (dependent on internal calcium stores) and tonic (dependent on calcium influx) contractions to NE were augmented in SHR femoral arteries in vitro. Nifedipine attenuated only tonic contractions but to a larger extent in SHR than in WKY arteries. Nifedipine effect was greater after endothelium removal, which augmented tonic but not phasic contractions after NE. Chronic captopril treatment of SHR prevented hypertension development by suppression of their sympathetic vasoconstriction including its nifedipine-sensitive component, but failed to influence enhanced NE-induced arterial contractions or increased relaxation to nifedipine in vitro. CONCLUSION: The contribution of nifedipine-sensitive component to noradrenergic vasoconstriction is enhanced during excessive NE stimulation (increased sympathetic tone of SHR in vivo or supramaximal NE stimulation in vitro). It seems that captopril-induced reduction of central sympathetic tone is able to normalize augmented nifedipine-sensitive vasoconstriction in SHR.

000      
00000naa 2200000 a 4500
001      
bmc10026684
003      
CZ-PrNML
005      
20111210192428.0
008      
101027s2007 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Paulis, Ľudovít $7 xx0093004
245    10
$a Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment / $c L Paulis, S Liskova, M Pinterova, Z Dobesova, J Kunes, J Zicha
314    __
$a Cardiovascular Research Center, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
520    9_
$a AIM: The relationship between increased sympathetic tone and enhanced activity of L-type voltage-dependent Ca2+ channels (L-VDCC) in spontaneously hypertensive rats (SHR) was studied using in vivo and in vitro approaches. METHODS: The effects of acute L-VDCC blockade on sympathetic vasoconstriction or blood pressure (BP) and the contribution of calcium influx to norepinephrine (NE)-induced arterial contraction were investigated in 10-week-old SHR and in age-matched SHR made normotensive by chronic captopril treatment from weaning. RESULTS: Blood pressure fall occurring after acute ganglionic or L-VDCC blockade was enhanced in SHR. Ganglionic blockade eliminated strain differences in BP response to acute L-VDCC blockade and vice versa, suggesting that enhanced contribution of L-VDCC is responsible for augmented sympathetic vasoconstriction in SHR. Both phasic (dependent on internal calcium stores) and tonic (dependent on calcium influx) contractions to NE were augmented in SHR femoral arteries in vitro. Nifedipine attenuated only tonic contractions but to a larger extent in SHR than in WKY arteries. Nifedipine effect was greater after endothelium removal, which augmented tonic but not phasic contractions after NE. Chronic captopril treatment of SHR prevented hypertension development by suppression of their sympathetic vasoconstriction including its nifedipine-sensitive component, but failed to influence enhanced NE-induced arterial contractions or increased relaxation to nifedipine in vitro. CONCLUSION: The contribution of nifedipine-sensitive component to noradrenergic vasoconstriction is enhanced during excessive NE stimulation (increased sympathetic tone of SHR in vivo or supramaximal NE stimulation in vitro). It seems that captopril-induced reduction of central sympathetic tone is able to normalize augmented nifedipine-sensitive vasoconstriction in SHR.
650    _2
$a agonisté adrenergních receptorů $x aplikace a dávkování $7 D000322
650    _2
$a zvířata $7 D000818
650    _2
$a antihypertenziva $x aplikace a dávkování $7 D000959
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a blokátory kalciových kanálů $x aplikace a dávkování $7 D002121
650    _2
$a vápníkové kanály - typ L $x metabolismus $7 D020746
650    _2
$a kaptopril $x aplikace a dávkování $7 D002216
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a adrenalin $x aplikace a dávkování $7 D004837
650    _2
$a hypertenze $x metabolismus $7 D006973
650    _2
$a gating iontového kanálu $x účinky léků $7 D015640
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a nifedipin $x aplikace a dávkování $7 D009543
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední SHR $7 D011918
650    _2
$a vazokonstrikce $x účinky léků $7 D014661
650    _2
$a financování organizované $7 D005381
700    1_
$a Líšková, Silvia $7 xx0096632
700    1_
$a Pintérová, Mária $7 xx0102050
700    1_
$a Dobešová, Zdena, $d 1947- $7 xx0074152
700    1_
$a Kuneš, Jaroslav, $d 1948- $7 nlk19990073450
700    1_
$a Zicha, Josef, $d 1950- $7 jk01152609
773    0_
$w MED00154561 $t Acta physiologica $g Roč. 191, č. 4 (2007), s. 255-266 $x 1748-1708
910    __
$a ABA008 $b x $y 7
990    __
$a 20101027095204 $b ABA008
991    __
$a 20101028141358 $b ABA008
999    __
$a ok $b bmc $g 801791 $s 666546
BAS    __
$a 3
BMC    __
$a 2007 $b 191 $c 4 $d 255-266 $m Acta physiologica $n Acta Physiol $x MED00154561
LZP    __
$a 2010-B3/vtme

Najít záznam